

IP69: Adrenal, Bladder & Urethra
Sunday, May 17, 2026 3:30 PM to 5:30 PM · 2 hr. (America/New_York)
146B
Poster and Podium Sessions
Adrenal
Sunday, May 17
IP69-01: Comparison of treatment outcomes between laparoscopic partial adrenalectomy and laparoscopic adrenalectomy for aldosterone producing adenoma
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-02: Real-World Patterns of Care and Survival Outcomes with Immunotherapy in Advanced Adrenocortical Carcinoma
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-03: Establishment and Evaluation of a Patient-Derived Organoids-based Xenograft Model of Primary Aldosteronism Using [18F]AlF-NOTA-pentixather PET/CT: Bridging Preclinical and Clinical Imaging
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
Xuezhou Zhang
IP69-04: Diagnostic Accuracy of Radiomics and Artificial Intelligence in Adrenal Tumor Characterization: A Sistematic Review
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-05: Predictors of Prolonged Length of Stay After Adrenalectomy: Development of a National Risk Prediction Model Using the ACS-NSQIP Database
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-06: Radiology Report Language Significantly Influences the Rate of Subsequent Workup for Adrenal Incidentalomas
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-07: Partial Adrenalectomy in Functional Tumors: An Underused Approach or a High-Risk Strategy?
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-08: Surgery Improves Long-Term Survival in Metastatic or Recurrent Pheochromocytoma and Paraganglioma: A 20-Year Single-Institution Review
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-09: single-nucleus RNA sequencing reveals the cellular composition and underlying mechanism of occurrence in adrenal myelolipoma
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-10: Machine learning-based identification of disulfidptosis-associated signature for improving outcomes and immunotherapy responses in patients with adrenocortical carcinoma
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-11: Rates of Adequate Testing for Cortisol Hypersecretion and Diagnosis of Mild Autonomous Cortisol Secretion (MACS) in a Single Institution Series of Adrenal Incidentalomas
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-12: Low-renin primary aldosteronism predicts superior surgical outcomes compared to high-renin disease
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
Ning Zhang
IP69-13: Predictive factors and a nomogram for haemodynamic instability during operation in Predictive factors and a nomogram for haemodynamic instability during operation in patients with pheochromocytomas and paragangliomas
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
Xuewen Jiang
IP69-14: Aldosterone levels are lower in primary aldosteronism patients taking statins than in those not taking statins at screening
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
Ning Zhang
IP69-15: From Trial to Practice: No Survival Benefit from Adjuvant Mitotane in Low-Risk Adrenocortical Carcinoma, Insights from a Nationwide Cohort
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-16: A Serotonergic Link Between Bladder and Bowel Dysfunction: Evidence from Male SERT Knockout Mice
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-17: Exploring collagen VI-macrophage interactions in the bladder toward a tissue engineered model of radiation cystitis
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-18: Effects of centrally administered histamine on the rat micturition reflex
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-19: Application and Mechanism of a Novel Polylactic Acid-Based Scaffold in Promoting Bladder Tissue Regeneration
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-20: USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY TO COMPARE HEART RATE VARIABILITY BETWEEN FEMALES WITH OVERACTIVE BLADDER AND HEALTHY CONTROLS PRE- AND POST-MICTURITION
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-21: A Prospective, Randomized Study Comparing Intravesical Micro-Radiofrequency Therapy to Oral Tolterodine in Patients with Newly Diagnosed Moderate-to-Severe Overactive Bladder
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
Li Jie
IP69-22: Magnetic resonance (MR) Fingerprinting Reveals Water Reabsorption from Human Bladder
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-23: Analyzing the Impact of Age and Location on Urethral Mechanics and the Proteome
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-24: De novo lower urinary tract symptoms after Robot Assisted Radical Prostatectomy: Evaluation Of incidence and risk factors
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
Fabio Maria Valenzi
IP69-25: What lies beneath:Neural Mapping of Pelvic Floor Muscles
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-26: Intravesical chitosan as a tunable model for rapid urothelial exfoliation
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B
IP69-27: Does Perirenal Fat Thickness (PFT) Affect Perioperative Outcomes in Transperitoneal Robot-Assisted Laparoscopic Adrenalectomy (RAA)?
Sunday, May 17, 2026 3:30 PM to 5:30 PM
146B

